Rothblatt left the company she founded, SiriusXM, in the early ’90s to start United Therapeutics in a bid to cure her daughter Jenesis’ pulmonary hypertension. Today Jenesis is thriving and the company’s sales are hitting record highs, led by the pulmonary arterial hypertension drug Tyvaso. A transgender rights activist, Rothblatt also led United’s transformation into a public benefit corporation, making it the first publicly traded pharmaceutical company to make the switch. Now she’s pushing to reduce the shortage of organs for people in need of transplants. In 2022, United orchestrated the first transplant of a gene-edited pig heart into a human, and it’s also experimenting with 3D-printed replacement organs.
More in Business
CEO, Gavi, the Vaccine Alliance
Chairman and CEO, Pfizer
CEO, U.S. operations, Eisai
Founder and president, ICER
The ultimate list of leaders in life sciences.View the List